Kane Biotech Stock Forward View - Triple Exponential Smoothing

Kane Biotech Additional Predictive Modules

Most predictive techniques to examine Kane price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kane using various technical indicators. When you analyze Kane charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Triple exponential smoothing for Kane Biotech - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Kane Biotech prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Kane Biotech price movement. However, neither of these exponential smoothing models address any seasonality of Kane Biotech.

Kane Biotech Triple Exponential Smoothing Price Forecast For the 16th of February 2026

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Kane Biotech on the next trading day is expected to be 0.04 with a mean absolute deviation of 0, mean absolute percentage error of 0.000017, and the sum of the absolute errors of 0.12.

Kane Biotech Stock Forecast Pattern

Backtest Kane Biotech

Kane Biotech Price Prediction

Research Analysis

Kane Biotech Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Kane Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Kane Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. As with simple exponential smoothing, in triple exponential smoothing models past Kane Biotech observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Kane Biotech observations.

Predictive Modules for Kane Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kane Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.03 11.35 Details

Intrinsic Valuation Low Real High 0.00 0.04 11.36 Details

Kane Biotech After-Hype Price Density Analysis

Kane Biotech Estimiated After-Hype Price Volatility

Kane Biotech Stock Price Outlook Analysis

Notes

Kane Biotech Hype Timeline

Kane Biotech is now traded for 0.04on TSX Venture Exchange of Canada. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Kane is estimated to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is over 100%. The price reduction on the next news is expected to be -25.0%, whereas the daily expected return is now at 0.61%. The volatility of related hype on Kane Biotech is about 132066.67%, with the expected price after the next announcement by competition of 0.03. About 43.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 13th of March 2017. Kane Biotech had 1:5 split on the 13th of March 2017. Assuming the 90 days horizon the next estimated press release will be in about 3 days. Check out Historical Fundamental Analysis of Kane Biotech to cross-verify your projections.

Kane Biotech Related Hype Analysis

Other Forecasting Options for Kane Biotech

For every potential investor in Kane, whether a beginner or expert, Kane Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kane Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kane. Basic forecasting techniques help filter out the noise by identifying Kane Biotech's price trends.

Kane Biotech Related Equities

Risk & Return

Correlation

Kane Biotech Market Strength Events

Kane Biotech Risk Indicators

Story Coverage note for Kane Biotech

Other Macroaxis Stories

Additional Tools for Kane Stock Analysis